Good morning, and welcome to Evelo Biosciences conference call to discuss its second-quarter 2021 financial results and business highlights. At this time, I'd like to turn the call over to Jessica Cotrone of Evelo. Today on our call, Simba Gill, chief executive officer; Mark Plinio, chief commercial officer; and Jonathan Zung, chief development officer, will review our recent business highlights and second-quarter 2021 financial results.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting